End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
109,600 KRW | +15.49% | +20.44% | +61.65% |
2023 | ST Pharm Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2021 | ST Pharm Co.,Ltd. Announces Expansion of Oligonucleotide Facility | CI |
ETFs positioned on ST Pharm Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.43% | 2 M€ | -14.14% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 7 M€ | +5.53% | - | |
0.00% | 114 M€ | +4.36% | - | |
0.00% | 32 M€ | +4.30% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+61.65% | 1.54B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.55% | 248B | |
-1.47% | 219B | |
+11.06% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- A237690 Stock
- Funds and ETFs ST Pharm Co.,Ltd.